Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1934111 | Biochemical and Biophysical Research Communications | 2008 | 5 Pages |
Abstract
Epigallocatechin gallate (EGCG) is known to have numerous pharmacological properties. In the present study, we have shown that EGCG inhibits enoyl-acyl carrier protein reductase of Plasmodium falciparum (PfENR) by following a two-step, slow, tight-binding inhibition mechanism. The association/isomerization rate constant (k5) of the reversible and loose PfENR-EGCG binary complex to a tight [PfENR-EGCG]â or EIâ complex was calculated to be 4.0 Ã 10â2 sâ1. The low dissociation rate constant (k6) of the [PfENR-EGCG]â complex confirms the tight-binding nature of EGCG. EGCG inhibited PfENR with the overall inhibition constant (Kiâ) of 7.0 ± 0.8 nM. Further, we also studied the effect of triclosan on the inhibitory activity of EGCG. Triclosan lowered the k6 of the EIâ complex by 100 times, lowering the overall Kiâ of EGCG to 97.5 ± 12.5 pM. The results support EGCG as a promising candidate for the development of tea catechin based antimalarial drugs.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Tanushree Banerjee, Shailendra Kumar Sharma, Namita Surolia, Avadhesha Surolia,